tykhr
sign in
free sign up
Vallon Pharmaceuticals Inc
Biotechnology
Healthcare
VLON
6.81 M shares
NASDAQ US
traded
04 May 2022
listed
yes
open
1.36
52 week high
9.68
high
1.39
52 week low
1.34
low
1.27
growth
-63.39 %
previous Close
1.46
P/E ratio
market cap
38.36 M
div yield
0
usd
Dec 2021
qoq
revenue
0.00 %
net incoming
-9.30 M
-640.10 %
eps
-149.32 %
eps surprise
-109.09 %
net profit margin
-930300000.00 %
0.00 %
operating incoming
-9.26 M
-638.95 %
net change in cash
3.59 M
178.52 %
cash on hand
3.70 M
-37.08 %
cost of revenue
0.00 %
top